Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2010
10/13/2010CN101857595A Quinnazolidone derivative, preparation method thereof and purpose of serving as anticarcinogen
10/13/2010CN101857594A Tetrahydropyridoindole compounds, and preparation method and application thereof
10/13/2010CN101857589A Pyrazol-benzimidazoles derivative and application thereof
10/13/2010CN101857588A 4-aromatic aminoquinazoline derivative and purpose thereof
10/13/2010CN101857584A Hydroxyl flavanoid compound and application thereof
10/13/2010CN101857583A Method for preparing isoflavone metal complexes and anti-tumor medical application
10/13/2010CN101857573A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/13/2010CN101857572A 4-aromatic amino pyrimidine derivative and application thereof
10/13/2010CN101857554A Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
10/13/2010CN101856501A Tumor targeted molecular chemotherapeutic gene-virus preparation SG500-deoxyribonucleoside kinase of drosophila melanogaster (SG500-Dm-dNK) and building method and application thereof
10/13/2010CN101856497A Conjugate of hapten and amino-containing carrier and preparation method and usage thereof
10/13/2010CN101856496A Placenta stem-cell anti-tumor vaccine, preparation method and application thereof
10/13/2010CN101856478A Chinese medicament for treating tumor
10/13/2010CN101856477A Chinese medicament for treating cancer and preparation method thereof
10/13/2010CN101856432A Preparation method of chitosan nanoparticles encapsulated tea polyphenol
10/13/2010CN101856427A Method for extracting solanine from potato peels
10/13/2010CN101856425A Externally applied medicine for alleviating cancer pain and preparation method thereof
10/13/2010CN101856393A Application of compound Yiganling composition in aspect of auxiliary treatment of chemotherapy of tumors
10/13/2010CN101856391A Medicament for treating cancer
10/13/2010CN101856380A Method for preparing active ingredient of yerbadetajo herb and application
10/13/2010CN101856379A Preparation method for Flos farfarae active constituent and application thereof
10/13/2010CN101856375A Preparation method and application of effective component of trumpetcreeper
10/13/2010CN101856368A Crocodile choline, preparation method and application thereof
10/13/2010CN101856364A Purpose and application of R'-beta-D-fructopyranoside in preparing medicament for preventing and treating cancer cell diffusion transfer
10/13/2010CN101856359A Medicine compound against acute myeloid leukemia
10/13/2010CN101856352A Synergistic effect of arteannuim and derivative thereof on chemotherapeutic agent
10/13/2010CN101856351A Composition and use thereof in preparation of RXR receptor transcription inhibitor
10/13/2010CN101856349A Curcumenol medicament for treating cancer and production method
10/13/2010CN101856348A Combination methods of treating cancer
10/13/2010CN101856346A Medical application of coumaroyl spermidine type compounds or plant extracts thereof
10/13/2010CN101856326A Method for preparing medical lycorine emulsion
10/13/2010CN101856325A Hydrochloric acid melphalan injection liquid and preparation method thereof
10/13/2010CN101856116A Application of coumaroyl spermidine type compounds or plant extracts thereof
10/13/2010CN101530408B Antineoplastic medicine composition and application thereof
10/13/2010CN101496579B Special diet and foodstuffs formula containing small peptide for tumor patient
10/13/2010CN101392262B Polypeptide of fungal ubuquitin-conjugating enzyme, coding sequence thereof and preparation method and application
10/13/2010CN101307059B Eriocalyxin B derivates, preparation method thereof and applications in antineoplastic drugs
10/13/2010CN101270145B Preparation technique for GHGKHKNK octapeptide and medicine use
10/13/2010CN101259103B Camptothecinum derivative emulsion agent and preparation thereof
10/13/2010CN101245107B Antihuman transferrin acceptor human source antibody and uses thereof
10/13/2010CN101244078B Medicament for treating hemangioma and preparation thereof
10/13/2010CN101234112B New purpose of cation carbazoles compounds
10/13/2010CN101219144B Long-circulation nano-grain of hydroxycamptothecin and method for preparing the same
10/13/2010CN101157715B Ursolic acid chemical modified compound amino alcohol having antitumor activity
10/13/2010CN101104609B Solanesyl polyamine derivative, preparation and application thereof
10/13/2010CN101084217B Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
10/13/2010CN101073564B Medicinal composition containing L-glutamine
10/13/2010CN101070349B Fusion protein with function of selective killing endothelial cells in tumor neogenetic blood vessels and use thereof
10/13/2010CN101054413B Tumor correlated albumen, coding gene and application thereof
10/13/2010CN101041629B New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/13/2010CN101035765B Sulfonamide derivatives
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7812165 6-substituted pyridoindolone derivatives, production and therapeutic use thereof
10/12/2010US7812058 Use of apogossypol derivatives to treat cancer; drug screening for Bcl-2 protein inhibitors
10/12/2010US7812052 Stable aqueous formulation of a platin derivative
10/12/2010US7812044 Hormone sensitive vcancer; antiproliferative agents ; induction apoptosis; angiotensin inhibitors
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812034 Using HIV protease inhibitors (indinavir, nelfinavir, ritonavir, or saquinavir) alone or in combination with chemotherapy, radiotherapy, or surgery
10/12/2010US7812004 For modifying and modulating the bacterial flora and the fermentation pattern of inulin in the large intestine; anticancer agents; dietary fibre effects, improved mineral absorption (calcium and magnesium), for treating osteoporosis
10/12/2010US7811997 From bamboo using carbon dioxide Supercritical Fluid Extraction; a mixture comprising friedelin,lupenone and homologues; hypotensive agents; anticarcinogenic agents; antitumor agents; free radical scavengers; oxidation resistance; cardiovascular disorders; sin, hair cosmetics; oral administration
10/12/2010US7811984 BV8 nucleic acids and polypeptides with mitogenic activity
10/12/2010US7811818 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders; useful in transplantation, for experimental evaluation, and as a source of lineage and cell specific products
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010US7811570 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell
10/12/2010US7811566 Antibody-induced apoptosis
10/12/2010CA2507259C Pharmaceutical composition containing bakuchiol for treating female breast cancer
10/12/2010CA2476164C Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
10/12/2010CA2467838C Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2438657C Testosterone-containing transdermal therapeutic system and process for its production
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2419205C Anti-tnf antibodies, compositions, methods and uses
10/12/2010CA2397964C Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2376305C Sulfonamide and sulfamide substituted imidazoquinolines
10/12/2010CA2375599C Probiotic compositions comprising e. coli and volatile fractions of plant extracts
10/12/2010CA2365266C Soybean protein nutraceuticals
10/12/2010CA2339034C Process for purifying human papillomavirus virus-like particles
10/12/2010CA2336114C Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
10/12/2010CA2313089C Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds
10/07/2010WO2010115130A1 Histidine derivatives and their pharmaceutical uses
10/07/2010WO2010115119A2 Compositions and methods for diagnosis and prognosis of cancer and progression, and for screening anti-cancer agents
10/07/2010WO2010115092A2 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer
10/07/2010WO2010114982A2 Lyophilization cakes of proteasome inhibitors
10/07/2010WO2010114940A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/07/2010WO2010114928A2 Compositions and uses thereof
10/07/2010WO2010114919A2 Metnase and intnase inhibitors and their use in treating cancer
10/07/2010WO2010114904A1 Pyrazolo-pyrrolopyridine-dione derivatives useful in the treatment of cancer
10/07/2010WO2010114902A1 Substituted tetrahydropyrazolo-pyrido-azepin compounds
10/07/2010WO2010114900A1 Substituted indolo-piperidine compounds
10/07/2010WO2010114898A1 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
10/07/2010WO2010114896A1 Substituted indolo-pyridinone compounds
10/07/2010WO2010114894A1 Substituted heterocyclic compounds
10/07/2010WO2010114539A1 Tumor targeting peptides, therapeutic and diagnostic compositions comprising the peptides
10/07/2010WO2010114494A1 8-substituted-2-morpholino purines for use as pi3k and/or mtor inhibitors in the treatment of proliferative disorders
10/07/2010WO2010114493A1 Lanthanide metal complexes useful in treating cancer
10/07/2010WO2010114484A1 Pyrimidine substituted purine compounds as kinase (s) inhibitors
10/07/2010WO2010114312A2 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
10/07/2010WO2010114185A1 Method for preparing dendritic cells with capacity to induce cancer-specific immune response, and pharmaceutical composition and kit incorporating dendritic cells for preventing or treating cancer or inhibiting metastasis
10/07/2010WO2010114179A1 3-[1,4]oxazepane-4-pyrimidone derivatives
1 ... 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 ... 2211